Elizabeth Cosgriff-Hernandez | |
---|---|
Born | Elizabeth Marie Christenson |
Alma mater | Case Western Reserve University |
Known for | Biomedical engineering |
Scientific career | |
Institutions | University of Texas at Austin Texas A&M University Rice University |
Thesis | Biostability and biocompatibility of modified polyurethane elastomers (2005) |
Doctoral advisor | Anne Hiltner |
Elizabeth Cosgriff-Hernandez is an American biomedical engineer who is a professor at the University of Texas at Austin. Her work involves the development of polymeric biomaterials for medical devices and tissue regeneration. She is a co-founder of Rhythio Medical, on the scientific advisory board of ECM Biosurgery, and a consultant to several companies on biostability evaluation of medical devices. Dr. Cosgriff-Hernandez is an associate editor of the Journal of Materials Chemistry B and Fellow of the International Union of Societies for Biomaterials Science and Engineering, Biomedical Engineering Society, Tissue Engineering and Regenerative Medicine International Society, American Chemical Society Division of Polymeric Materials: Science and Engineering, Royal Society of Chemistry, and the American Institute for Medical and Biological Engineering.
Cosgriff-Hernandez was an undergraduate student at Case Western Reserve University, majoring in biomedical engineering. She focused on macromolecular science and engineering for her graduate studies, where she worked under the supervision of Drs. Anne Hiltner and Jim Anderson. Cosgriff-Hernandez was appointed as a UT-TORCH postdoctoral fellow at Rice University, where she focused on orthopaedic tissue engineering under the direction of Dr. Tony Mikos. [1]
Dr. Cosgriff-Hernandez joined the faculty of the Biomedical Engineering Department at Texas A&M University in 2007 prior to moving to University of Texas at Austin in 2017. Her laboratory specializes in the development of polymeric biomaterials to improve clinical outcomes of medical devices and regeneration strategies in the areas of orthopaedics, cardiovascular devices, chronic wound healing, and women’s health. Synthesis of new biomaterials with targeted cell interactions is complemented by advanced fabrication strategies. In addition to providing improved medical devices and tissue grafts, these innovative biomaterials provide new tools to probe complex processes of tissue function and remodeling. She is a co-founder of Rhythio Medical, on the scientific advisory board of ECM Biosurgery, and a consultant to several companies on biostability evaluation of medical devices. Dr. Cosgriff-Hernandez is an Associate Editor of the Journal of Materials Chemistry B and has previously served as an Associate Editor of the Journal of Biomedical Materials Research, Part B and chair of the NIH study section on Musculoskeletal Tissue Engineering. [1]
Alongside her research on novel materials, Cosgriff-Hernandez is involved with initiatives to promote equity and diversity within the sciences. She has served on the Diversity Committee of the Biomedical Engineering Society, DEI Committee of the Society for Biomaterials, and Chair of the Women's Initiatives Committee of the American Institute of Chemical Engineers. In 2020, she partnered with Kelly Stevens, Karmella Haynes, Lola Eniola-Adefeso to investigate disparities in National Institutes of Health funding for Black researchers. [2]
A biomaterial is a substance that has been engineered to interact with biological systems for a medical purpose – either a therapeutic or a diagnostic one. The corresponding field of study, called biomaterials science or biomaterials engineering, is about fifty years old. It has experienced steady growth over its history, with many companies investing large amounts of money into the development of new products. Biomaterials science encompasses elements of medicine, biology, chemistry, tissue engineering and materials science.
Ali Khademhosseini is an Iranian-born Canadian-American engineer. He is the CEO of the Terasaki Institute, non-profit research organization in Los Angeles, and Omeat Inc., a cultivated-meat startup. Before taking his current CEO roles, he spent one year at Amazon Inc. Prior to that he was the Levi Knight chair and professor at the University of California-Los Angeles where he held a multi-departmental professorship in Bioengineering, Radiology, Chemical, and Biomolecular Engineering as well as the Director of Center for Minimally Invasive Therapeutics (C-MIT). From 2005 to 2017, he was a professor at Harvard Medical School, and the Wyss Institute for Biologically Inspired Engineering.
Nicholas (Nikolaos) A. Peppas is a chemical and biomedical engineer whose leadership in biomaterials science and engineering, drug delivery, bionanotechnology, pharmaceutical sciences, chemical and polymer engineering has provided seminal foundations based on the physics and mathematical theories of nanoscale, macromolecular processes and drug/protein transport and has led to numerous biomedical products or devices.
The American Institute for Medical and Biological Engineering (AIMBE) is a non-profit organization founded in 1991, and headquartered in Washington, D.C. It represents 50,000 medical and biomedical engineers, and academic institutions, private industry, and professional engineering societies.
Ravi V. Bellamkonda is an Indian-American biomedical engineer and academic administrator. Since 2021, he has served as Provost and Executive Vice President for Academic Affairs at Emory University in Atlanta, Georgia. Bellamkonda was previously Vinik Dean of the Pratt School of Engineering at Duke University.
Anthony Steven Weiss is an Australian university researcher, company founder and entrepreneur. He is the leading scientist in human tropoelastin research and synthetic human elastin. He holds the McCaughey Chair in Biochemistry, heads the Charles Perkins Centre Node in Tissue Engineering and Regenerative Medicine, and is Professor of Biochemistry and Molecular Biotechnology at the University of Sydney. His discoveries are on human elastic materials that accelerate the healing and repair of arteries, skin and 3D human tissue components. He is a Fellow of the Royal Society of Chemistry. Weiss is on the editorial boards of the American Chemical Society Biomaterials Science and Engineering, Applied Materials Today (Elsevier), Biomaterials, Biomedical Materials, BioNanoScience (Springer) and Tissue Engineering. He is a biotechnology company founder, promoter of national and international technology development, and has received national and international awards, including the Order of Australia.
Alan J. Russell, is Vice President of Biologics for Amgen, one of the world’s leading Biopharmaceutical companies. Until 2020, Alan was the Highmark Distinguished Career Professor and Director of the Disruptive Health Technology Institute at Carnegie Mellon University. From 2013 through spring of 2016 he was also the Chief Innovation Officer, Allegheny Health Network.
Antonios Georgios Mikos is a Greek-American biomedical engineer who is the Louis Calder Professor of Bioengineering and Chemical and Biomolecular Engineering at Rice University. He specialises in biomaterials, drug delivery, and tissue engineering.
Jennifer Hartt Elisseeff is an American biomedical engineer, ophthalmologist and academic. She is the Morton Goldberg Professor and Director of the Translational Tissue Engineering Center at Johns Hopkins Department of Biomedical Engineering and the Wilmer Eye Institute with appointments in Chemical Engineering, Biomedical Engineering, Materials Science and Orthopedic Surgery. Elisseeff's research is in the fields of regenerative medicine and immunoengineering.
Akhilesh K. Gaharwar is an Indian academic and a professor in the Department of Biomedical Engineering at Texas A&M University.
Omolola (Lola) Eniola-Adefeso is a Nigerian-American chemical engineer and incoming Dean of the College of Engineering at the University of Illinois Chicago.
Guillermo Antonio Ameer is the Daniel Hale Williams Professor of biomedical engineering at the Robert R. McCormick School of Engineering and Applied Science and Surgery at the Feinberg School of Medicine of Northwestern University and is a fellow of the American Institute for Medical and Biological Engineering, Biomedical Engineering Society, American Institute of Chemical Engineers, American Association for the Advancement of Science, Materials Research Society, and American Academy of Arts and Sciences. He is an engineer, inventor, and entrepreneur.
Joyce Y. Wong is an American engineer who is Professor of Biomedical Engineering and Materials Science and Engineering at Boston University. Her research develops novel biomaterials for the early detection treatment of disease. Wong is the Inaugural Director of the Provost's Initiative to promote gender equality and inclusion in STEM at all levels: Advance, Recruit, Retain and Organize Women in STEM. She is a Fellow of the American Association for the Advancement of Science, American Institute for Medical and Biological Engineering and Biomedical Engineering Society.
Kristi Lynn Kiick is the Blue and Gold Distinguished Professor of Materials Science and Engineering at the University of Delaware. She studies polymers, biomaterials and hydrogels for drug delivery and regenerative medicine. She is a Fellow of the American Chemical Society, the American Institute for Medical and Biological Engineering, and of the National Academy of Inventors. She served for nearly eight years as the deputy dean of the college of engineering at the University of Delaware.
Christine E. Schmidt is an American biomedical engineer. As a professor at the University of Florida, Schmidt was inducted into the Florida Inventors Hall of Fame for her creation of the Avance Nerve Graft which has "improved the lives of numerous patients suffering from peripheral nerve damage."
Melissa F. Grunlan is an American scientist and academic. She is Professor and Holder of the Charles H. and Bettye Barclay Professorship in the Department of Biomedical Engineering at Texas A&M University. She holds courtesy appointments in the Departments of Chemistry and Materials Science & Engineering. Her research focuses on the development of polymeric biomaterials for regenerative engineering and medical devices.
Tatiana Segura is an American biomedical engineer who is a professor at Duke University. Her research considers biomedical engineering solutions to promote cell growth. She was elected Fellow of the American Institute for Medical and Biological Engineering in 2017 and awarded the Acta Biomaterialia Silver Medal in 2021.
Karen Leigh Christman is an American bioengineer who is the Associate Dean for Faculty Affairs and the Pierre Galletti Endowed Chair for Bioengineering Innovation at University of California, San Diego. Her research considers regenerative medicine and tissue engineering. She was elected a Fellow of the National Academy of Inventors in 2023.
Deborah E. Leckband is an American chemist who is the Reid T. Milner Professor of Chemical Sciences and professor of chemistry at the University of Illinois Urbana-Champaign. She works on biomaterials, tissue engineering and the nano mechanics of biomolecules. She is a Fellow of the American Institute for Medical and Biological Engineering, the American Association for the Advancement of Science, the Biomedical Engineering Society and the American Chemical Society.
Ashutosh Chilkoti is an Indian American biomedical engineer, academic, researcher and serial entrepreneur. He is the Alan L. Kaganov Professor of Biomedical Engineering and Senior Associate Dean in the Pratt School of Engineering at Duke University.